| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/21/2013 | EP2627673A1 Therapies for improving pulmonary function |
| 08/21/2013 | EP2627635A1 Salts of arylsulfonamide ccr3 antagonists |
| 08/21/2013 | EP2627355A1 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material |
| 08/21/2013 | EP2627354A1 Suppression of a type 1 hypersensitivity immune response with an unrelated antigen |
| 08/21/2013 | EP2627341A2 Coriolus versicolor extracts, methods of preparation and uses thereof |
| 08/21/2013 | EP2627332A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 08/21/2013 | EP2379497B1 Hemifumarate salt of 1- ý4- ý1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl¨-2 -ethyl-benzyl¨-a zetidine-3-carboxylic acid |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
| 08/21/2013 | CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same |
| 08/21/2013 | CN103260629A Composition for use in treating and preventing inflammation related disorder |
| 08/21/2013 | CN103260627A Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd). |
| 08/21/2013 | CN103255187A Low molecular hyaluronate, preparation method and purpose thereof |
| 08/21/2013 | CN103255169A Replication-defective arenavirus vectors |
| 08/21/2013 | CN103255076A Bacillus spp and hyaluronidase and preparation method and purpose thereof |
| 08/21/2013 | CN103255021A Health preserving wine |
| 08/21/2013 | CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors |
| 08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 08/21/2013 | CN103254155A Tetrahydropyrrole derivative and preparation method thereof |
| 08/21/2013 | CN103251953A Flt3 inhibitors for immune suppression |
| 08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 08/21/2013 | CN103251944A Preparation method of ursolic acid as immunologic adjuvant vaccine and use |
| 08/21/2013 | CN103251896A Medicated bath prescription and preparation method thereof |
| 08/21/2013 | CN103251840A Veterinary traditional Chinese medicine for tonifying qi and strengthening exterior |
| 08/21/2013 | CN103251816A Preparation for enhancing immunity and preparation method thereof |
| 08/21/2013 | CN103251815A Zhuyan medicinal liquor |
| 08/21/2013 | CN103251802A Appearance paste and preparation method thereof |
| 08/21/2013 | CN103251800A Traditional Chinese medicine composition for treating allergic dermatitis |
| 08/21/2013 | CN103251773A Chinese medicine composite for treating pig high fever |
| 08/21/2013 | CN103251765A Traditional Chinese medicine composition for treating lumbar intervertebral disc herniation and preparation method thereof |
| 08/21/2013 | CN103251764A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 08/21/2013 | CN103251743A Formulation for enhancing immunity, improving cardiovascular function and delaying senescence |
| 08/21/2013 | CN103251737A Yindan capsule |
| 08/21/2013 | CN103251734A Traditional Chinese medicine health-care preparation with cistanche and acanthopanax as main medicines |
| 08/21/2013 | CN103251729A Radix astragali and Mythic fungus tablet |
| 08/21/2013 | CN103251715A Composition for regulating Th1/Th2 cell ratio and preparation method thereof |
| 08/21/2013 | CN103251654A Pearl powder vitamin C and E capsule and preparation method thereof |
| 08/21/2013 | CN103251601A Use of carboxyamidotriazole (cai) orotate in macular degeneration |
| 08/21/2013 | CN103251567A Agomelatine troche and preparation method thereof |
| 08/21/2013 | CN103251563A Stable granular medicine composition containing epinastine or hydrochloride thereof |
| 08/21/2013 | CN103251532A Tea flower skin cream containing tea flower |
| 08/21/2013 | CN102743578B Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction |
| 08/21/2013 | CN102727750B Pharmaceutical composition for benefiting Yang and detoxifying and preparation method and application thereof |
| 08/21/2013 | CN102657260B Antiallergic lactobacillus |
| 08/21/2013 | CN102580047B Chinese medicinal pills for treating kidney-deficiency asthma |
| 08/21/2013 | CN102552921B Montelukast sodium composition |
| 08/21/2013 | CN102512520B Normal-temperature preparation method for ultrafine powder hawthorn |
| 08/21/2013 | CN102512389B Fexofenadine hydrochloride oral disintegrating drug composition |
| 08/21/2013 | CN102397436B Tea cream for treating allergic rhinitis and preparation method thereof |
| 08/21/2013 | CN102127056B Tubulin inhibitors |
| 08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
| 08/21/2013 | CN102068398B Allergy-relieving, anti-inflammatory and anti-irritation skin-care composition, preparation and preparation method thereof |
| 08/21/2013 | CN102026647B Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 08/21/2013 | CN101790517B Inhibitor of binding of s1p1 |
| 08/20/2013 | US8513300 Allergic rhinitis, asthma, rheumatoid arthritis or an autoimmune disease; Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC) as delivery agent |
| 08/20/2013 | US8513220 Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity |
| 08/20/2013 | US8512719 Oat extracts: refining, compositions and methods of use |
| 08/20/2013 | US8512718 Pharmaceutical composition for topical application |
| 08/20/2013 | US8512709 Modified amyloid β peptide |
| 08/20/2013 | CA2559036C 9-substituted 8-oxoadenine compound |
| 08/20/2013 | CA2508660C Antibodies against pd-1 and uses therefor |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/20/2013 | CA2445349C Anti-cd40 monoclonal antibody |
| 08/15/2013 | WO2013119791A1 Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use |
| 08/15/2013 | WO2013118126A1 Ladostigil therapy for immunomodulation |
| 08/15/2013 | WO2013118033A1 NOVEL BINDING SITE OF ΙΚΚ-β |
| 08/15/2013 | WO2013117348A1 Agonists and antagonists of toll-like receptor (tlr) 13 |
| 08/15/2013 | WO2013064703A3 Fkbp subtype-specific rapamycin analogue for use in treatment of diseases |
| 08/15/2013 | WO2013030670A3 Tissue targeted fusobacterium antigenic activation of the immune response to treat intestinal cancers |
| 08/15/2013 | WO2013029634A3 Natural antioxidant anti-influenza composition |
| 08/15/2013 | US20130212740 Fucosyl transferase gene |
| 08/15/2013 | US20130210875 Novel binding site of IKK-beta |
| 08/15/2013 | US20130209517 Cancer therapy |
| 08/15/2013 | US20130209456 Subtypes of humanized antibody against interleukin-6 receptor |
| 08/15/2013 | US20130209395 Nucleic acid molecule encoding hepatitis b virus core protein and surface antigen protein and vaccine comprising the same |
| 08/14/2013 | EP2626076A1 Composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system |
| 08/14/2013 | EP2625204A1 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor |
| 08/14/2013 | EP2624846A2 Nanoparticle-loaded cells |
| 08/14/2013 | EP2624845A2 Enhanced msc preparations |
| 08/14/2013 | EP2624822A2 Allergen deactivator composition, articles and methods |
| 08/14/2013 | CN103243119A Expression and preparation method of soluble CD83 |
| 08/14/2013 | CN103243009A Female beautifying blueberry wine |
| 08/14/2013 | CN103242451A Multivalent immunoglobulin-based bioactive assemblies |
| 08/14/2013 | CN103242448A Full-humanized anti-PD-1 monoclonal antibody and preparation method and application thereof |
| 08/14/2013 | CN103242447A Tweak binding antibodies |
| 08/14/2013 | CN103242444A Modulation of SIRP-alpha - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 08/14/2013 | CN103242341A Thieno 2,4-substituted pyrimidine compound, and pharmaceutical composition and application thereof |
| 08/14/2013 | CN103242230A Quinolinone derivative and preparation method thereof |
| 08/14/2013 | CN103239726A Stable and long-acting rhIL2-HSA fusion protein liquid preparation |
| 08/14/2013 | CN103239684A Zedoary oil injection and preparation method thereof |
| 08/14/2013 | CN103239673A Traditional Chinese medicine composition for preventing and curing sudden death syndrome of cow |
| 08/14/2013 | CN103239639A Traditional Chinese medicine for treating anaphylactoid purpura |
| 08/14/2013 | CN103239629A Chinese medicine composition for reducing stress of livestock and poultry and preparation method of Chinese medicine composition |
| 08/14/2013 | CN103239628A Wine preparation for warming and tonifying kidney yang, enhancing immunity and warding off diseases and strengthening body |
| 08/14/2013 | CN103239587A Chinese medicine composition of capsule for dredging collaterals and invigorating blood circulation and preparation method of Chinese medicine composition |
| 08/14/2013 | CN103239561A Domesticated sika deer fetus extract and preparation method thereof |
| 08/14/2013 | CN103239553A Traditional Chinese medicine composition for treating anaphylactoid purpura |
| 08/14/2013 | CN103239552A Traditional Chinese medicine preparation for treating anaphylactoid purpura |
| 08/14/2013 | CN103239511A Traditional Chinese medicine composition for treating allergic rhinitis |